OTCQX:MRVFF - Post by User
Post by
kurtwalteron Feb 02, 2015 11:24am
387 Views
Post# 23388151
Fabrice Taylor and the Nuvo selloff
Fabrice Taylor and the Nuvo selloffF
abrice Taylor is head of the President's Club, an investment advisory service somehow associated with the Globe and Mail. Last week he probably caused a sellfoff on high-flying PHM by advising his subscribers to sell, while he later stated on BNN-TV that he meant to say to take profits,.
On Nuvo he has been even more of a disaster by blatantly misinterpreting the results, probably contributing to the sell-off.. In the latest phase the placebo group performed better than in the previous phase, probably because low allergy conditions were prevalent. But Fabrice Taylor concluded that the drug performed worse than placebo, which is not supported by the news release. That states:"Each of the Active Arms demonstrated a greater reduction in TNSS than placebo." Taylor writes:
"Nuvo Research (NRI.TO): I expected the WF10 results next month, because that’s what the company told me. But they got the results earlier than expected and released them today. They were not good. While WF10 peformed well, the placebo performed even better, nullifying the result of the drug. The company is evaluating its options which could include a new Phase 2 study."